Business Wire

Corona and Parley for the Oceans partner with Stephanie Gilmore, Gabriel Medina and artists to support the ban of single-use plastic in Bali and provide households with reusable alternatives.

Share

It is estimated that roughly 5 trillion plastic bags are consumed worldwide each year1 with as many as 10 million plastic bags entering circulation in Indonesia every day2. Earlier this year, Bali announced a ban of all single-use plastic (including plastic bags) that takes affect later this year. For the first time, Balinese would have to rely on reusable bags exclusively.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190514005361/en/

Corona's La Casa pop-up space, made from 1.5 tons of recycled plastic. (Photo: Business Wire)

Corona's La Casa pop-up space, made from 1.5 tons of recycled plastic. (Photo: Business Wire)

To help support the local NGOs who have been leading the charge against single-use plastic and as part of their commitment to the region where the annual Bali Pro-tected surf event takes place, Corona, Parley and World Surf League are donating 20,000 reusable bags made from Ocean Plastic®. Limited edition bags are also being created on-site and will be sold in real-time at wslstore.com. The proceeds from each bag purchased funds the donation of an additional 3 bags to the local community and the removal of more than 20 bottles worth of plastic. The ambition over time is to provide one bag for every household in Indonesia.

The limited-edition bags were designed by Stephanie Gilmore, Gabriel Medina and Rosy Hodge in partnership with artists Nadia Hernandez, Speto and Gemma O’Brien respectively. Surfers on the WSL Championship Tour have also shown their support by designing their own bags to raise awareness of the project. The collaborators are part of the inaugural “La Casa” pop-up, a house made from 1.5 tons of recycled plastic in partnership with NevHouse. Founded by Corona, the house will become a platform for surfers, artists and thought-leaders to work on projects that can inspire a better world. The house itself is a positive reminder that plastic can be given a meaningful second life, much like the bags. Each pop-up will include new collaborators and new projects to help protect paradise from plastic pollution.

“The La Casa platform is about collaboration and creativity to energize the fight against marine plastic pollution,” said Evan Ellman, Corona Better World Director. “In this case, Corona and our partners Parley and World Surf League, were inspired by the movement to ban single-use plastic in Bali and recognized an opportunity to support the transition. Just as impressive are the talented collaborators who signed on to bring their voice and point of view to the project. The result is a product that is not only a symbol of change, but also has a significant impact on the environment and community.”

La Casa is the latest initiative from Corona and Parley for the Oceans who have a mutual mission to protect the world’s oceans and beaches. To date, the partnership has engaged in 100 islands around the world through a clean-up network present in over 23 countries, resulting in 537 clean-ups, 25,000 volunteers and more than 3 million square meters of beach cleaned. This includes Corona’s support of Parley’s strategy to end marine plastic pollution: A.I.R. (Avoid, Intercept and Redesign). Most recently, Corona and Parley partnered with Oscar-nominated stop-motion artist PES to create a film on Earth Day raising awareness that “avoiding” and “intercepting” plastic saves the lives of marine wildlife. The La Casa initiative in Bali is an example of how that plastic can be “redesigned” into a product that replaces single-use plastic.

La Casa Corona will be at the Corona Bali Pro-tected event in Keramas, Bali, Indonesia from May 13 - May 25, 2019. To learn more and purchase a bag visit wslstore.com.

-###-

ABOUT CORONA

Born in Mexico, Corona is the leading beer brand in the country, the most popular Mexican beer worldwide exported to more than 180 countries. Corona Extra was first brewed in 1925 at the Cervecería Modelo in Mexico City. Corona is a pioneer in the beer industry by being the first to use a transparent bottle showcasing its purity and high quality to the world. The artwork found on the bottle is painted, highlighting our commitment to quality in our packaging and our Mexican heritage. No Corona is complete without the lime. Naturally adding character, flavor and refreshment, the lime ritual is an integral part of delivering an experience that is truly unique to Corona. The brand is synonymous with the beach and celebrates time outdoors. It invites people to pause, relax and enjoy the simple pleasures of life.

ABOUT PARLEY FOR THE OCEANS

Parley for the Oceans is the global network where creators, thinkers and leaders from the creative industries, brands, governments and environmental groups come together to raise awareness for the beauty and fragility of the oceans and collaborate on projects that can end their destruction. The organization has formed alliances with major corporations including adidas, Anheuser Busch InBev (Corona), American Express; the United Nations; the Maldives and collaborators spanning the worlds of science, art, fashion, design, entertainment, sports, and space and ocean exploration. To know more: www.parley.tv

ABOUT THE WSL

The World Surf League (WSL) is the global home of surfing, dedicated to celebrating the world's best surfing on the world's best waves. The WSL has been championing the world's best surfing since 1976, annually running more than 180 global events across the Men's and Women's Championship Tours, the Big Wave Tour, the Longboard Tour, Qualifying Series, Pro Junior Tour, as well as the WSL Big Wave Awards. The League possesses a deep appreciation for the sport's rich heritage while promoting progression, innovation, and performance at the highest levels, and in doing so crowns the undisputed Men’s and Women’s World Champions across all tours. For more information, please visit WorldSurfLeague.com.

1 https://wedocs.unep.org/bitstream/handle/20.500.11822/25513/state_plastics_WED.pdf?isAllowed=y&sequence=1
2 https://www.theinertia.com/environment/indonesia-pledges-1-billion-a-year-to-reduce-its-ocean-waste/

Contact information

Alison Brod Marketing + Communications:
Corona@alisonbrodmc.com
212-230-1800

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FDA Approves OTEZLA® (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease19.7.2019 20:59:00 EESTPress release

Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has approved OTEZLA® (apremilast) 30 mg twice daily (BID) for the treatment of adult patients with oral ulcers associated with Behçet’s Disease. OTEZLA, an oral, selective inhibitor of phosphodiesterase 4 (PDE4), is the first and only approved treatment option for oral ulcers associated with Behçet’s Disease, a rare, chronic, multisystem inflammatory disease that is difficult to treat. “Oral ulcers are a recurring and debilitating manifestation that affects nearly everyone living with Behçet’s Disease, and have an important negative impact on the quality of life for these patients,” said Yusuf Yazici, M.D., Clinical Associate Professor, Department of Medicine, New York University Langone Health. “In the clinical trial, OTEZLA demonstrated improvements in measures of oral ulcers at week 12. OTEZLA has the potential to be a needed treatment option for U.S. patients and their physicians, who

Abiraterone Acetate Included in World Health Organisation’s Essential Medicines List for the Treatment of Metastatic Castration-Resistant Prostate Cancer19.7.2019 16:05:00 EESTPress release

The Janssen Pharmaceutical Companies of Johnson & Johnson is delighted with the recent announcement from the World Health Organisation (WHO) to include abiraterone acetate (ZYTIGA ® ) for the treatment of metastatic castration-resistant prostate cancer (mCRPC), in the updated Essential Medicines List, published on 9th July 2019.1,2 The WHO’s Essential Medicines List is a core guidance document that helps countries prioritise critical health products that are recommended to be widely available and affordable throughout health systems.1 “The inclusion of abiraterone acetate in the WHO Essential Medicines List highlights the critical role that this treatment can play in improving the lives of patients living with mCRPC and their families,” said Dr. Joaquín Casariego, Janssen Therapeutic Area Lead Oncology for Europe, Middle East & Africa, Janssen-Cilag S.A. “I am proud that we are working hard to impact survival and quality of life by developing and providing innovative medicines which ar

Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis19.7.2019 15:30:00 EESTPress release

Gilead Sciences, Inc. (NASDAQ: GILD) announced today that it has licensed three preclinical antiviral programs from Novartis, including investigational agents with the potential to treat human rhinovirus, influenza and herpes viruses. Under the agreement, Gilead will acquire exclusive global rights to develop and commercialize novel small molecules against three undisclosed targets. Novartis will receive an upfront payment and is eligible to receive up to an additional $291 million in potential milestone payments upon achievement of certain development and commercial milestones, as well as royalties on annual net sales. “Today’s announcement builds on Gilead’s heritage in antiviral research and development. We look forward to applying this expertise to advance the development of potential new treatments for viruses with limited therapeutic options,” said John McHutchison AO, MD, Gilead’s Chief Scientific Officer and Head of Research and Development. Gilead’s antiviral portfolio include

Schlumberger Announces Second-Quarter 2019 Results19.7.2019 14:00:00 EESTPress release

Schlumberger Limited (NYSE: SLB) today reported results for the second quarter of 2019. (Stated in millions, except per share amounts) Three Months Ended Change Jun. 30, 2019 Mar. 31, 2019 Jun. 30, 2018 Sequential Year-on-year Revenue $8,269 $7,879 $8,303 5% 0% Pretax segment operating income $968 $908 $1,094 7% -12% Pretax segment operating margin 11.7% 11.5% 13.2% 17 bps -148 bps Net income - GAAP basis $492 $421 $430 17% 14% Net income, excluding charges & credits* $492 $421 $594 17% -17% Diluted EPS - GAAP basis $0.35 $0.30 $0.31 17% 13% Diluted EPS, excluding charges & credits* $0.35 $0.30 $0.43 17% -19% North America revenue $2,801 $2,738 $3,139 2% -11% International revenue $5,463 $5,037 $5,065 8% 8% North America revenue, excluding Cameron $2,243 $2,178 $2,546 3% -12% International revenue, excluding Cameron $4,761 $4,469 $4,387 7% 9% *These are non-GAAP financial measures. See section titled "Charges & Credits" for details. Schlumberger Chairman and CEO Paal Kibsgaard commente

Schlumberger Appoints Olivier Le Peuch as CEO19.7.2019 13:46:00 EESTPress release

Schlumberger Limited (NYSE: SLB) announced today that its Board of Directors has appointed Olivier Le Peuch as its Chief Executive Officer and member of the Schlumberger Board, effective August 1, 2019. Mr. Le Peuch succeeds Paal Kibsgaard, who will retire as Chief Executive Officer effective that same date. Also effective August 1, Mr. Kibsgaard will step down as Chairman of the Board and retire as a member of the Board of Directors. Mr. Kibsgaard will retire after more than 22 years of service to the Company, including eight years as CEO and four years as Chairman. Effective the same date, Mark G. Papa, a current non-independent director, will become non-executive Chairman of the Board. Peter Currie will continue to serve as the Board’s Lead Independent Director. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190719005161/en/ Olivier Le Peuch is appointed Chief Executive Officer and a member of the Schlumberger Board, effe

Fluke Corporation Acquires Industrial Reliability Leader PRÜFTECHNIK19.7.2019 13:00:00 EESTPress release

Fluke Corp., the global leader in test and measurement instruments, has acquired Ismaning, Germany-based PRÜFTECHNIK, a market leader in precision laser shaft alignment, condition monitoring, and non-destructive testing. “Fluke’s acquisition of PRÜFTECHNIK reflects the growing importance our customers place on reliability systems to keep their equipment in optimum operating condition,” said Marc Tremblay, president of Fluke Corporation. “This business will help us usher in the next generation of solutions for our industrial customers.” Fluke Corporation For information on Fluke tools and applications, or to find the location of your nearest distributor, contact Fluke Corporation, P.O. Box 9090, Everett, WA USA 98206, call (800) 44-FLUKE (800-443-5853), fax (425) 446-5116, e-mail fluke-info@fluke.com or visit the Fluke Web site at http://www.fluke.com. About Fluke Founded in 1948, Fluke Corporation is the world leader in compact, professional electronic test tools and software for measu

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom